Pharmafile Logo
Pharmafocus logo
Advanced Search

WHO

Showing 15 posts of 102 posts found.

WHO flag

Encouraging first results from trial of Merck’s Ebola vaccine

July 31, 2015
Research and Development, Sales and Marketing Africa, EBV, Ebola, Ebola virus, Ebola virus disease, Vaccine, WHO, World Health Organisation, guinea, vaccination

The first trial of an experimental Ebola vaccine suggests it provides high protection against the disease as early as ten …

News
Vaccination

EMA backs GSK’s malaria vaccine for use in Africa

July 24, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CHMP, Committee for Medicinal Products for Human USE, EMA, European Medicines Agency, GSK, WHO, malaria, world health organization

GSK has taken a significant step forward toward being the first company to bring a malaria vaccine to market, after …

News
WHO flag

Novartis receives WHO nod for malaria drug Coartem

July 17, 2015
Manufacturing and Production Coartem, Novartis, WHO, antimalarial, malaria, world health organization

The World Health Organization will add Novartis’ antimalarial treatment Coartem to the prequalified list of vaccines that is supplies to …

News
vaccine image

China flu vaccine gets WHO seal of approval

June 12, 2015
Research and Development, Sales and Marketing Hualan Biological Bacterin, WHO, influenza

A Chinese influenza vaccine has been deemed safe and effective by The World Health Organization (WHO). The approval makes its …

News

World Health Organisation calls for full trial transparency

April 14, 2015
Research and Development, Sales and Marketing Ben Goldacre, EU, WHO, World Health Organisation, alltrials, clinical trials, sense about science, transparency

The World Health Organization has thrown its weight behind clinical trial transparency in a new statement on its position. WHO …

News

WHO: New measures needed to reduce high drug costs

March 26, 2015
Research and Development, Sales and Marketing Europe, WHO, pricing, transparency, world health organization

New approaches to drug pricing and reimbursement are needed to make sure pharma provides access to new medicines, according to …

News
Merck image

Merck and NewLink Ebola vaccine trial begins

March 6, 2015
Sales and Marketing Ebola, Merck, Vaccine, WHO, newlink, rVSV-EBOV

Merck and US-based biopharma firm NewLink Genetics’ investigational Ebola vaccine is being used in Phase III trials in West Africa. …

News
flu image

Flu vaccine ineffective against this season’s strain

February 6, 2015
Research and Development, Sales and Marketing A(H3N2, Public Health England, UK, Vaccine, WHO, flu, phe

This season’s flu vaccine has provided little protection against the main strain circulating in the UK according to a new …

News
GSK image

GSK launches Ebola Phase III trial in Liberia

January 23, 2015
Research and Development, Sales and Marketing Africa, Ebola, GSK, US National Institutes of Health, WHO, Wellcome Trust, liberia, newlink

A shipment of GSK’s potential vaccine against the Ebola virus disease is on its way to Liberia ready to be …

News

Gilead and Strides partner in HIV

January 21, 2015
Research and Development, Sales and Marketing Cipla, FDA, Gilead, HIV, Ranbaxy, Tenofovir Alafenamide, WHO, strides, taf

Gilead is partnering with India-based pharma firm Strides Arcolab in a licensing agreement to manufacture and distribute an HIV treatment …

News
Ebola image

UK nurse with Ebola in ‘critical condition’

January 6, 2015
Research and Development, Sales and Marketing Africa, Ebola, GSK, Mapp, WHO, cafferky, johnson, zmapp

A British nurse that was diagnosed with Ebola last week is said to be in a critical condition at the …

News
GSK image

GSK Ebola vaccine gets EU support

December 17, 2014
Research and Development, Sales and Marketing EC, EU, Ebola, Europe, GSK, Merck, Takeda, Vaccine, WHO, johnson

A newly-formed European consortium is to help advance the development of GlaxoSmithKline’s promising Ebola vaccine. The consortium is backed by …

News
Vaccine image

Gavi pledges $300 million for Ebola vaccines

December 12, 2014
Manufacturing and Production, Sales and Marketing GAVI, GSK, GlaxoSmithKline, J&J, JJ, Merck, Vaccine, WHO, newlink

The global vaccines alliance Gavi has committed to buying Ebola vaccines as soon as the World Health Organization recommends one …

News
Merck image

Merck Ebola vaccine shows promise

December 4, 2014
Research and Development, Sales and Marketing Ebola, Merck, VSV-ZEBOV, WHO, hug, newlink genetics

Merck and NewLink Genetics’ experimental Ebola vaccine has shown no major side effects in its first trial according to the …

News
FDA image

FDA clears Sanofi TB drug indication

December 2, 2014
Research and Development, Sales and Marketing Bedaquiline, FDA, Sanofi, WHO, priftin, rifapentine, sirturo

The FDA has approved Sanofi’s Priftin for a new tuberculosis (TB) indication following a priority review from the regulator. Priftin …

News

Latest content

Regeneron shares data for multiple myeloma treatment

December 8, 2023

Merck collaborates with Acceleration Consortium for AI experimentation

December 8, 2023

AbbVie to acquire Cerevel Therapeutics for approximately $8.7bn

December 7, 2023

ONK Therapeutics and NAYA Biosciences enter partnership for NK cell therapy development

December 7, 2023

FDA approves Novartis’ Fabhalta for PNH treatment

December 6, 2023